[Federal Register Volume 83, Number 15 (Tuesday, January 23, 2018)]
[Notices]
[Pages 3173-3174]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-01082]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of the Secretary; Notice of Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of meetings of the Task Force on 
Research Specific to Pregnant Women and Lactating Women.
    The meetings will be open to the public, with attendance limited to 
space available. Individuals who plan to attend and need special 
assistance, such as sign language interpretation or other reasonable 
accommodations, should notify the Contact Person listed below in 
advance of the meeting.

    Name of Committee: Task Force on Research Specific to Pregnant 
Women and Lactating Women.
    Date: February 26-27, 2018.
    Time: February 26, 2018, 8:30 a.m. to 5:00 p.m.; February 27, 2018, 
8:00 a.m. to 3:00 p.m.
    Agenda: The Task Force is charged with providing advice and 
guidance to the Secretary of HHS, regarding Federal activities related 
to identifying and addressing gaps in knowledge and research regarding 
safe and effective therapies for pregnant women and lactating women, 
including the development of such therapies and the collaboration on 
and coordination of such activities.

February 26th, 2018--Day 1

8:30 a.m.--Welcome and Opening Remarks
8:40 a.m.--Introductions
8:45 a.m.--Summary and Discussion of work products from meetings 1 and 
2
10:45 a.m.--Follow-up on Task Force Request regarding Lessons learned 
from Pediatrics
1:15 p.m.--Effective communication strategies with health care 
providers and the public on information relevant to pregnant women and 
lactating women
1:50 p.m.--Panel: Effective communication strategies with health care 
providers on information relevant to pregnant women and lactating women
3:30 p.m.--Panel: Effective communication strategies with the public on 
information relevant to pregnant women and lactating women.
4:10 p.m.--Discussion
5:00 p.m.--End of Day 1

February 27th, 2018--Day 2

8:00 a.m.--Recap from Day 1, Outline & Goals of Day 2
8:15 a.m.--Panel and open discussion to cover specific questions on the 
options for a plan or plans to identify and address gaps in knowledge 
and research regarding safe and effective therapies for pregnant women 
and lactating women, including the development of such therapies.
12:45 p.m.--Discussion of Key Points related to topic: Effective 
communication strategies with health care providers and the public on 
information relevant to pregnant women and lactating women
1:30 p.m.--Discussion of Key Points related to topic: A plan to 
identify and address gaps in knowledge and research regarding safe and 
effective therapies for pregnant women and lactating women, including 
the development of such therapies
2:15 p.m.--Review of Recommendations from TF1-3
2:45 p.m.--Action Items, Charge to Group
3:00 p.m.--Adjournment

    Place: 6710B Rockledge Drive, Room 1425/1427 (1st Floor), Bethesda, 
MD 20817.
    Contact Person: Ms. Lisa Kaeser, Executive Secretary, Eunice 
Kennedy Shriver National Institute of Child Health and Human 
Development, 31 Center Drive, Room 2A03, MSC 2425, Bethesda, MD 20892, 
(301) 496-0536, [email protected].
    Public comments are welcome either by filing written comments and/
or providing oral comments at the meeting. Oral comments from the 
public will be scheduled on February 26, 2018, from approximately 10:00 
a.m.-10:45 a.m. Any member of the public interested in presenting oral 
comments on February 26, 2018, should submit a letter of intent, a 
brief description of the organization represented, and the oral 
presentation to Ms. Lisa Kaeser ([email protected]) by 5:00 p.m. on 
Monday, February 19, 2018. Written

[[Page 3174]]

comments to be included at the meeting should also be sent to Lisa 
Kaeser by 5:00 p.m. on Monday, February 19, 2018.
    The submitted presentations and any written comments will be 
formatted to be posted on the PRGLAC website for the record. Only one 
representative of an organization may be allowed to present oral 
comments. Presentations will be limited to three to five minutes per 
speaker depending on the number of speakers to be accommodated within 
the allotted time. Speakers will be assigned a time to speak in the 
order of the date and time when their request to speak is received. 
Both printed and electronic copies are requested for the record.
    Details and additional information about these meetings can be 
found at the NICHD website for the Task Force on Research Specific to 
Pregnant Women and Lactating Women (PRGLAC) https://www.nichd.nih.gov/about/advisory/PRGLAC/Pages/index.aspx.

    Dated: January 17, 2018.
Michelle Trout,
Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-01082 Filed 1-22-18; 8:45 am]
 BILLING CODE 4140-01-P